Geneos Wealth Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Geneos Wealth Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-136	Closed	-$1K	–	2483
2018 Q4	$1K	Hold	136	–	–	﹤0.01%	2354
2018 Q3	$2K	Buy	+136	New	+$2.94K	﹤0.01%	2295
2018 Q2	–	Sell	-136	Closed	-$2K	–	2350
2018 Q1	$2K	Hold	136	–	–	﹤0.01%	2074
2017 Q4	$2K	Sell	136 -2,080	-94%	-$37.7K	﹤0.01%	2067
2017 Q3	$31K	Hold	2,216	–	–	﹤0.01%	1161
2017 Q2	$16K	Hold	2,216	–	–	﹤0.01%	1371
2017 Q1	$14K	Sell	2,216 -20	-0.9%	-$112	﹤0.01%	1384
2016 Q4	$9K	Hold	2,236	–	–	﹤0.01%	1486
2016 Q3	$10K	Hold	2,236	–	–	﹤0.01%	1380
2016 Q2	$14K	Hold	2,236	–	–	﹤0.01%	1241
2016 Q1	$14K	Buy	+2,236	New	+$11.5K	﹤0.01%	1213

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geneos Wealth Management's SPPI Position: Q1 2019 in Review

Geneos Wealth Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2019, closing a stake of 136 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in SPPI in Q1 2016 and held it in 11 quarters. The position peaked at $31K in Q3 2017. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

Geneos Wealth Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
Geneos Wealth Management sold 136 Spectrum Pharmaceuticals Inc shares in Q1 2019, an estimated $1K.
Geneos Wealth Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 11 quarters.
Geneos Wealth Management's Spectrum Pharmaceuticals Inc position peaked at $31K in Q3 2017.
173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on Geneos Wealth Management's 13F filing for Q1 2019, filed 7 Sep 2021.